Your browser doesn't support javascript.
loading
A report of three cases with lupus myelitis.
Oiwa, Hiroshi; Yamabe, Toru; Kawashima, Masanori; Maetani, Yuta; Agari, Dai; Yamawaki, Takemori; Sugiyama, Eiji.
Afiliación
  • Oiwa H; Department of Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Yamabe T; Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Kawashima M; Department of Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Maetani Y; Department of General Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Agari D; Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Yamawaki T; Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Sugiyama E; Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Eur J Rheumatol ; 4(2): 148-150, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28638692
Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE). In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings. Here we describe three cases of this disorder, one with signs of white matter dysfunction and two with signs of gray matter dysfunction. We discuss the potential role of autoantibodies in the development of LM.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Rheumatol Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Rheumatol Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Turquía